Drawing for PHAROS

USPTO serial 90542897

PHAROS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EVANKO, PATRICIA MALESARDI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHAROS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark A. Jansen, Esq.

Mark A. Jansen, Esq. FENWICK & WEST LLP801 CALIFORNIA STREETSILICON VALLEY CENTERMOUNTAIN VIEW, CA 94041-1990

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for tracking, categorizing, and analyzing various types of plants; downloadable software for tracking, categorizing, and analyzing plant-based and plant-derived medicines and therapies; downloadable software for mining databases of plant-based and plant derived medicines and treatments; downloadable software for collecting, processing, analyzing, transmitting, sharing, and validating information on the efficacy of plant-based and plant-derived medical treatmentsACTIVE—
035Providing medical business consulting; business administration and management of health and medicine treatment programs; charitable services in the nature of coordination, organization, administration, and management of medical services and humanitarian assistance; promoting public awareness, knowledge, understanding and support of and for medical diseases and conditionsACTIVE—
041Educational services, namely, providing online non-downloadable videos, pamphlets, journals, and articles in the field of plant-based and plant-derived medicine and therapy; providing non-downloadable videos and multimedia content in the field of plant-based and plant-derived medicine and therapyACTIVE—
042Providing a temporary use of non-downloadable software for tracking, organizing, categorizing, collecting, sharing, transmitting, and analyzing data in the field of plant-based and plant-derived medicines and therapies; platform as a service (PAAS) featuring software platforms for tracking, organizing, categorizing, collecting, sharing, transmitting, and analyzing data in the field of plant-based and plant-derived medicines and therapies; providing a temporary use of non-downloadable software for tracking, categorizing, and analyzing various types of plants; platform as a service (PAAS) featuring software platforms for tracking, categorizing, and analyzing various types of plants; providing a temporary use of non-downloadable software for tracking, categorizing, and analyzing plant-based and plant-derived medicines and therapies; platform as a service (PAAS) featuring software platforms for tracking, categorizing, and analyzing plant-based and plant-derived medicines and therapies; providing a temporary use of non-downloadable software for mining databases of plant-based and plant-derived medicines and treatments; platform as a service (PAAS) featuring software platforms for mining databases of medicines and treatments; providing a temporary use of non-downloadable software for collecting, processing, analyzing, transmitting, sharing, and validating information on the efficacy of plant-based and plant-derived medical treatments; platform as a service (PAAS) featuring software platforms for collecting, processing, analyzing, transmitting, sharing, and validating information on the efficacy of plant-based and plant-derived medical treatments; providing a temporary use of non-downloadable software for conducting a convergence analysis in the field of plant-based and plant-derived medicine; platform as a service (PAAS) featuring software platforms for conducting a convergence analysis in the field of plant-based and plant-derived medicine; research and development of plant-based or plant-derived therapeutics and preparationsACTIVE—
044Medical services; treatment and diagnosis of medical diseases and conditions; providing medical therapy and treatments; providing medical therapy and treatments using plant-based and plant-derived preparations; providing an online medical database; medical assistance services; medical assistance services in the nature of medical information provided via the Internet, online databases, and global computer networks; international medical relief services; providing medical information about medicine and therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 9, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 9, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2025EX5GSOU EXTENSION 5 GRANTED—
Jun 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2025EXT5SOU EXTENSION 5 FILED—
Jan 23, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2025EX4GSOU EXTENSION 4 GRANTED—
Dec 16, 2024EXT4SOU EXTENSION 4 FILED—
Dec 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 28, 2024EX3GSOU EXTENSION 3 GRANTED—
Jun 28, 2024EXT3SOU EXTENSION 3 FILED—
Jun 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 20, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 18, 2023EX2GSOU EXTENSION 2 GRANTED—
Dec 18, 2023EXT2SOU EXTENSION 2 FILED—
Dec 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2023UNTDREQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN—
Jun 5, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 12, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 10, 2023EX1GSOU EXTENSION 1 GRANTED—
May 10, 2023EXT1SOU EXTENSION 1 FILED—
May 10, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 10, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 15, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 15, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 12, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 6, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 6, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 6, 2022ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Apr 6, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 6, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 6, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 19, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 18, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2021DOCKASSIGNED TO EXAMINER—
May 25, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance